ArticleGastroenterology and hepatology from bed to bench2013
Quality of life in patients with gastroesophageal reflux disease in an Iranian population.
Article in Gastroenterology and hepatology from bed to bench, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 17 citations in OpenAlex.
- Prevalence and risk factors of gastroesophageal reflux disease symptoms in Mazandaran, North of Iran: A Tabari cohort study.Caspian journal of internal medicine · 2024Article
- Factors influencing the quality of life of GERD patients in the Aseer Region, Saudi Arabia.Journal of family medicine and primary care · 2023Article
- The Role of a Plant-Only (Vegan) Diet in Gastroesophageal Reflux Disease: Online Survey of the Italian General Population.Nutrients · 2023Article
- Quality of life and severity of symptoms among patients with various degrees of reflux esophagitis: a prospective study.Scientific reports · 2023Article
- Prevalence and risk factors of gastroesophageal reflux disease in a rural Indian population.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021Article
- Is Estrogen a Curse or a Blessing in Disguise? Role of Estrogen in Gastroesophageal Reflux Disease.Cureus · 2020Review
- Article
- Lung function parameters in patients with gastroesophageal reflux without respiratory symptoms: a case-control study.Gastroenterology and hepatology from bed to bench · 2019Article
- Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease; A Randomized Double Blind Clinical Trial.Middle East journal of digestive diseases · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe study was designed to evaluate quality of life (QOL) for Iranian patients with gastroesophageal reflux disease (GERD).
backgroundGERD is a common and chronic world-wide disease. Impact of GERD on QOL has been studied in many countries, but it has not been studied in Iranian population. PATIENTS AND
methodsFifty five patients suffering from GERD and fifty five age and sex matched controls were enrolled. Patient inclusion criteria were based on clinical and endoscopic findings. All other major diseases having an impact on QOL had been excluded. All the subjects were asked to fill the validated translation of SF-36 and GHQ-28 questionnaires. Results of the SF-36 questionnaire was analyzed directly and after correction for the results obtained from the GHQ-28 tool.
resultsGERD patients had lower QOL scores than controls. Correction of the results based the findings of GHQ-28 questionnaire did not change the results.
conclusionQOL in GERD patients is impaired and should be considered in clinical practice and implementing research studies upon GERD patients.
Indexed as
Identifiers
24834252PMC4017503W2100401080What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.